Skip to content
PubMed This is a summary of 19 peer-reviewed journal articles Updated
Benign Thyroid Nodule

When Should Benign Thyroid Nodules Be Rebiopsied or Treated?

At a Glance

Growth alone usually does not mean a benign thyroid nodule needs repeat biopsy. Rebiopsy is more likely for suspicious ultrasound features, abnormal lymph nodes, or a mismatch between the scan and biopsy; treatment may be considered for symptoms, excess thyroid hormone, or recurrent cysts.

Hearing that a fine-needle aspiration (FNA) biopsy is “benign” (non-cancerous) is reassuring, but it does not mean your care is completely finished. In a multinodular goiter (an enlarged thyroid with multiple nodules), a benign biopsy only applies to the specific nodule that was sampled [1]. Other nodules in your thyroid have their own risk profiles and may need separate evaluation [1]. Furthermore, because benign nodules can grow and sometimes develop new features, you may still need a personalized plan for monitoring or treatment [2][3].

Understanding Nodule Growth

Patients commonly worry that if a benign nodule grows, it must have turned into cancer. However, benign thyroid nodules frequently enlarge over time [4][5]. In fact, growth alone is a relatively weak predictor of cancer [2].

When doctors look for growth, they are not concerned with millimeter-by-millimeter variations, which can sometimes just be the result of a different ultrasound technician measuring the nodule [6]. Clinically meaningful growth is generally defined as a 20% increase in at least two dimensions (with at least a 2-millimeter increase in each), or a more than 50% increase in total volume [7]. Even when a nodule meets this definition of significant growth, it is still very likely to remain benign if the ultrasound features are low-suspicion [2].

While size alone does not prove cancer, your doctor might discuss surgery for very large nodules (often 4 cm or larger) due to a slightly higher risk of false-negative biopsies, inward growth (substernal extension), or your personal preference even if symptoms are limited [8][9].

When is a Repeat Biopsy Needed?

Your doctor will look at the entire picture during any follow-up ultrasounds. A repeat biopsy may be necessary in the following situations:

  • New suspicious ultrasound features: This is a much stronger reason to repeat an FNA than growth alone. If the nodule develops irregular margins, tiny bright spots of calcium (microcalcifications), or a “taller-than-wide” shape, your doctor will likely recommend sampling it again [2].
  • Suspicious lymph nodes: If abnormal lymph nodes are found in your neck, they will need to be evaluated and possibly biopsied [10].
  • Persistent sampling concerns: Sometimes the way a nodule looks on an ultrasound is highly suspicious, but the biopsy comes back benign. Because it is possible for the needle to miss the cancerous cells, this “mismatch” often warrants a repeat ultrasound-guided biopsy [11]. If a biopsy result was “non-diagnostic” (meaning not enough cells were collected), it should be repeated with ultrasound guidance [12]. If a nodule is repeatedly non-diagnostic, your doctor might suggest a core-needle biopsy, expert review, molecular testing, or diagnostic surgery [13].

When is Treatment Recommended for a Benign Nodule?

Even if a nodule is definitively benign, there are several reasons you might still need treatment:

  • Compressive symptoms: If a goiter grows large enough to press on your windpipe or esophagus, it can cause difficulty breathing, trouble swallowing, voice changes, or a feeling of pressure in the neck [3]. Safety note: Seek prompt medical assessment for any severe or rapidly worsening airway or swallowing symptoms.
  • Cosmetic concerns: A nodule that becomes visibly noticeable or cosmetically bothersome can be treated [9].
  • Thyroid hormone excess: Sometimes a benign nodule begins producing too much thyroid hormone on its own. This is called an autonomously functioning or “toxic” nodule. This causes hyperthyroidism. If you have symptoms like rapid heartbeat or unexplained weight loss, your doctor will check your thyroid stimulating hormone (TSH) blood levels and may order a radionuclide scan [14]. While anti-thyroid medications can offer temporary control, definitive treatments include surgery or radioactive iodine (which is not used during pregnancy). Thermal ablation (using heat to shrink the nodule) is also an option for select patients depending on local expertise [14][15].
  • Recurrent fluid: Some benign nodules are cysts filled with fluid. If they are drained but repeatedly fill back up and cause symptoms, they can be treated with specialized procedures like percutaneous ethanol injection (injecting alcohol into the cyst to shrink it) or thermal ablation [1][16].

Your Individualized Surveillance Plan

There is no single follow-up schedule for every patient. Instead, your doctor will base your surveillance plan on the nodule’s initial ultrasound risk pattern, size, and whether you have had one or two adequately targeted benign FNAs [1][17].

For example, very low-risk nodules may need little to no routine follow-up. According to medical guidelines, if a nodule has been biopsied twice and found to be benign both times, routine ultrasound surveillance for cancer is generally no longer required, though your clinician might still individualize your care if you have highly suspicious ultrasound features or if new symptoms develop [18][19]. The goal is a tailored approach that balances safety with minimizing unnecessary procedures and anxiety.

Common questions in this guide

Does growth of a benign thyroid nodule mean it has become cancerous?
No. Benign thyroid nodules often grow, and growth alone is a relatively weak sign of cancer. Doctors pay more attention to meaningful growth together with new suspicious ultrasound features, such as irregular edges, tiny calcium spots, or a taller-than-wide shape.
When should a benign thyroid nodule be biopsied again?
A repeat ultrasound-guided biopsy may be recommended if the nodule develops suspicious ultrasound features, abnormal neck lymph nodes appear, or the ultrasound looks worrisome despite a benign result. A biopsy that did not collect enough cells usually needs to be repeated with ultrasound guidance.
Why would a benign thyroid nodule need treatment?
Treatment may be considered if a nodule presses on the windpipe or esophagus, causes breathing, swallowing, or voice symptoms, becomes cosmetically bothersome, produces too much thyroid hormone, or repeatedly refills after drainage. Options can include surgery, radioactive iodine, thermal ablation, or ethanol injection, depending on the situation.
How is a thyroid nodule that makes too much hormone evaluated?
Your clinician may check TSH and other thyroid-function blood tests and may order a radionuclide scan to see whether a nodule is making excess hormone. Treatment options may include surgery, radioactive iodine, or thermal ablation; radioactive iodine is not used during pregnancy.
Do I still need ultrasound follow-up after two benign biopsies?
For many nodules, routine ultrasound surveillance for cancer is no longer needed after two adequately targeted benign biopsies. Follow-up may still be individualized if ultrasound features are highly suspicious or new symptoms develop.

Get notified when new evidence is published on multinodular goiter.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (19)
  1. 1

    AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ASSOCIAZIONE MEDICI ENDOCRINOLOGI MEDICAL GUIDELINES FOR CLINICAL PRACTICE FOR THE DIAGNOSIS AND MANAGEMENT OF THYROID NODULES--2016 UPDATE.

    Gharib H, Papini E, Garber JR, et al.

    Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2016; (22(5)):622-39 doi:10.4158/EP161208.GL.

    PMID: 27167915
  2. 2

    What Is the Best Criterion for Repetition of Fine-Needle Aspiration in Thyroid Nodules with Initially Benign Cytology?

    Rosário PW, Calsolari MR

    Thyroid : official journal of the American Thyroid Association 2015; (25(10)):1115-20 doi:10.1089/thy.2015.0253.

    PMID: 26148539
  3. 3

    The Diagnosis and Management of Thyroid Nodules: A Review.

    Durante C, Grani G, Lamartina L, et al.

    JAMA 2018; (319(9)):914-924 doi:10.1001/jama.2018.0898.

    PMID: 29509871
  4. 4

    Changes in the Volume and Diameter of Benign Thyroid Nodules: A 10-Year Follow-Up Study.

    Erdoğan MF, Bahçecioğlu AB, Avcı Merdin F, et al.

    Thyroid : official journal of the American Thyroid Association 2025; (35(1)):31-40 doi:10.1089/thy.2024.0405.

    PMID: 39692610
  5. 5

    The natural history of benign thyroid nodules.

    Durante C, Costante G, Lucisano G, et al.

    JAMA 2015; (313(9)):926-35 doi:10.1001/jama.2015.0956.

    PMID: 25734734
  6. 6

    Inter-observer variation in ultrasound measurement of the volume and diameter of thyroid nodules.

    Choi YJ, Baek JH, Hong MJ, Lee JH

    Korean journal of radiology 2015; (16(3)):560-5 doi:10.3348/kjr.2015.16.3.560.

    PMID: 25995685
  7. 7

    2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.

    Haugen BR, Alexander EK, Bible KC, et al.

    Thyroid : official journal of the American Thyroid Association 2016; (26(1)):1-133 doi:10.1089/thy.2015.0020.

    PMID: 26462967
  8. 8

    Thyroid nodules over 4 cm do not have higher malignancy or benign cytology false-negative rates.

    Kizilgul M, Shrestha R, Radulescu A, et al.

    Endocrine 2019; (66(2)):249-253 doi:10.1007/s12020-019-01964-3.

    PMID: 31144224
  9. 9

    Thyroid nodules: diagnosis and management.

    Wong R, Farrell SG, Grossmann M

    The Medical journal of Australia 2018; (209(2)):92-98 doi:10.5694/mja17.01204.

    PMID: 29996756
  10. 10

    Comparison of thyroid fine needle aspiration biopsy and ultrasonography results.

    Keskin L, Karahan D, Yaprak B

    Medicine 2023; (102(26)):e33822 doi:10.1097/MD.0000000000033822.

    PMID: 37390290
  11. 11

    Comparison between Sonographic Features and Fine Needle Aspiration Cytology with Histopathology in the Diagnosis of Solitary Thyroid Nodule.

    De D, Dutta S, Tarafdar S, et al.

    Indian journal of endocrinology and metabolism 2020; (24(4)):349-354 doi:10.4103/ijem.IJEM_349_20.

    PMID: 33088759
  12. 12

    [Fine-needle Aspiration of Thyroid Nodules: Is it Worth Repeating?]

    Fernandes V, Pereira T, Eloy C

    Acta medica portuguesa 2017; (30(6)):472-478 doi:10.20344/amp.8215.

    PMID: 28898614
  13. 13

    THE ROLE OF CORE-NEEDLE BIOPSY FOR THYROID NODULES WITH INITIALLY NONDIAGNOSTIC FINE-NEEDLE ASPIRATION RESULTS: A SYSTEMATIC REVIEW AND META-ANALYSIS.

    Suh CH, Baek JH, Kim KW, et al.

    Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2016; (22(6)):679-88 doi:10.4158/EP15986.OR.

    PMID: 27176143
  14. 14

    2020 European Thyroid Association Clinical Practice Guideline for the Use of Image-Guided Ablation in Benign Thyroid Nodules.

    Papini E, Monpeyssen H, Frasoldati A, Hegedüs L

    European thyroid journal 2020; (9(4)):172-185 doi:10.1159/000508484.

    PMID: 32903999
  15. 15

    SFE-AFCE-SFMN 2022 Consensus on the management of thyroid nodules : What is the role of functional imaging and isotopic treatment?

    Thuillier P, Benisvy D, Ansquer C, et al.

    Annales d'endocrinologie 2022; (83(6)):401-406 doi:10.1016/j.ando.2022.10.008.

    PMID: 36273578
  16. 16

    Minimally-invasive treatments for benign thyroid nodules: a Delphi-based consensus statement from the Italian minimally-invasive treatments of the thyroid (MITT) group.

    Papini E, Pacella CM, Solbiati LA, et al.

    International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 2019; (36(1)):376-382 doi:10.1080/02656736.2019.1575482.

    PMID: 30909759
  17. 17

    Long-Term Surveillance for Benign Thyroid Nodules.

    Macera M, Melcarne R, Grani G

    Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2026; (32(1)):77-86 doi:10.1016/j.eprac.2025.07.021.

    PMID: 40769308
  18. 18

    Thyroid nodules with highly suspicious ultrasonographic features, but with benign cytology on two occasions: is malignancy still possible?

    Rosário PW, Calsolari MR

    Archives of endocrinology and metabolism 2016; (60(4)):402-4.

    PMID: 27533616
  19. 19

    Validation of American Thyroid Association Ultrasound Risk-Adapted Approach for Repeating Cytology in Benign Thyroid Nodules.

    Maino F, Bufano A, Dalmazio G, et al.

    Thyroid : official journal of the American Thyroid Association 2021; (31(3)):446-451 doi:10.1089/thy.2020.0351.

    PMID: 32718278

This page is for informational purposes only and does not constitute medical advice. A thyroid clinician should interpret your ultrasound, biopsy, thyroid-function tests, symptoms, and preferences when deciding whether to repeat a biopsy or treat a nodule.